carvedilol has been researched along with Fatty Liver in 1 studies
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition, factors potentially involved in hepatic ischemia-reperfusion injury, including oxidative stress (malondialdehyde and superoxide anion levels), mitochondrial damage (glutamate dehydrogenase activity), microcirculatory disorders (flow rate and vascular resistance), and adenosine triphosphate (ATP) depletion, were evaluated after reperfusion." | 3.76 | Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation. ( Alfany-Fernandez, I; Ben Abdennebi, H; Ben Mosbah, I; Boillot, O; Lojek, A; Mitjavila, MT; Parellada, PP; Peralta, C; Rimola, A; Rodés, J; Roselló-Catafau, J, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben Mosbah, I | 1 |
| Roselló-Catafau, J | 1 |
| Alfany-Fernandez, I | 1 |
| Rimola, A | 1 |
| Parellada, PP | 1 |
| Mitjavila, MT | 1 |
| Lojek, A | 1 |
| Ben Abdennebi, H | 1 |
| Boillot, O | 1 |
| Rodés, J | 1 |
| Peralta, C | 1 |
1 other study available for carvedilol and Fatty Liver
| Article | Year |
|---|---|
Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation.
Topics: Adenosine; Adenosine Triphosphate; Adenylate Kinase; Adrenergic beta-Antagonists; Allopurinol; Anima | 2010 |